Efficacy of Streptokinase, but Not Tissue-Type Plasminogen Activator, in Achieving 90-Minute Patency After Thrombolysis for Acute Myocardial Infarction Decreases With Time to Treatment
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference15 articles.
1. The effects of tPA, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction;N Engl J Med,1993
2. Angiographic monitoring of reperfusion therapy for acute myocardial infarction;Stadius;Circulation,1993
3. Optimal management of acute myocardial infarction requires early and complete reperfusion;Kennedy;Circulation,1995
4. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tPA and intravenous streptokinase. Clinical findings through hospital discharge;Chesebro;Circulation,1987
5. Anderson JL, Rothbard RL, Hackworthy RA, et al., for the APSAC Multicenter Investigators. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase. J Am Coll Cardiol 1988;11:1153–63.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Model development and comparison of low hemorrhage-risk endoluminal patch thrombolytic treatment for ischemic stroke;Medical Engineering & Physics;2018-11
2. Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials;Critical Care;2016-11-05
3. A study of coronary artery patency in relation to the index event in patients with myocardial infarction thrombolysed with streptokinase;Heart Asia;2014-04-28
4. American Versus European Guidelines: Critical Appraisal;Pharmacological Treatment of Acute Coronary Syndromes;2013-08-14
5. Duration of Symptoms Is Not Always the Key Modulator of the Choice of Reperfusion for ST-Elevation Myocardial Infarction;Circulation;2009-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3